Table 2. Open in new tab Numbers and... | Oxford Academic

Table 2.

Open in new tab

Numbers and Annualized Rates (%) for Hip Fractures

	Placebo				Treatment				HR	Lower CL	Upper CL	P
	n	Hip Fractures	Follow-Up (mo)	%	n	Hip Fractures	Follow-Up (mo)	%	HR	Lower CL	Upper CL	P
CEE + MPA	5159	56	50.1	0.26	4975	50	49.95	0.24	0.93	0.63	1.36	0.70
CEE alone	2532	29	51.4	0.27	2521	30	51.50	0.28	1.04	0.62	1.73	0.89

	Placebo				Treatment				HR	Lower CL	Upper CL	P
	n	Hip Fractures	Follow-Up (mo)	%	n	Hip Fractures	Follow-Up (mo)	%	HR	Lower CL	Upper CL	P
CEE + MPA	5159	56	50.1	0.26	4975	50	49.95	0.24	0.93	0.63	1.36	0.70
CEE alone	2532	29	51.4	0.27	2521	30	51.50	0.28	1.04	0.62	1.73	0.89

Abbreviation: CL, confidence limit.

Table 2.

Open in new tab

Numbers and Annualized Rates (%) for Hip Fractures

	Placebo				Treatment				HR	Lower CL	Upper CL	P
	n	Hip Fractures	Follow-Up (mo)	%	n	Hip Fractures	Follow-Up (mo)	%	HR	Lower CL	Upper CL	P
CEE + MPA	5159	56	50.1	0.26	4975	50	49.95	0.24	0.93	0.63	1.36	0.70
CEE alone	2532	29	51.4	0.27	2521	30	51.50	0.28	1.04	0.62	1.73	0.89

	Placebo				Treatment				HR	Lower CL	Upper CL	P
	n	Hip Fractures	Follow-Up (mo)	%	n	Hip Fractures	Follow-Up (mo)	%	HR	Lower CL	Upper CL	P
CEE + MPA	5159	56	50.1	0.26	4975	50	49.95	0.24	0.93	0.63	1.36	0.70
CEE alone	2532	29	51.4	0.27	2521	30	51.50	0.28	1.04	0.62	1.73	0.89

Abbreviation: CL, confidence limit.